| Quarter | Score |
|---|---|
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 36.0 |
| 2023-Q3 | 50.4 |
| 2023-Q4 | 42.8 |
| 2024-Q1 | 43.7 |
| 2024-Q2 | 79.9 |
| 2024-Q3 | 85.7 |
| 2024-Q4 | 81.0 |
| 2025-Q1 | 82.6 |
| 2025-Q2 | 80.9 |
| 2025-Q3 | 82.0 |
| 2025-Q4 | 80.0 |
| 2026-Q1 | 80.2 |
| 2026-Q2 | 79.5 |
High consensus with active accumulation at an attractive valuation
Trading 54.0% below funds' estimated purchase price
3 of 18 tracked funds hold LBTYA. Avg conviction: 0.9%. Net adding. First tracked at $19.88 (current -54.0% vs tracked).
Greenlight Capital has 1.4% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 1.4% | Hold |
| Oaktree Capital | 1.3% | Hold |
| Citadel Advisors | 0.0% | Add |